# FDA 483 - Conopco, Inc - April 06, 2022

Source: https://www.globalkeysolutions.net/records/483/conopco-inc/9f6da736-76db-4bcd-929e-da64af1c0c82

> FDA 483 for Conopco, Inc on April 06, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Conopco, Inc
- Inspection Date: 2022-04-06
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West II
- Summary: An FDA inspection of Conopco, Inc. in Jefferson City, MO, revealed significant deficiencies in quality control practices for OTC drug manufacturing. Observations included failures to properly sample, test, and release components and drug product containers, inadequate laboratory controls for raw material identification, and a lack of annual visual examination of reserve samples for deterioration. These issues indicate a lack of adherence to good manufacturing practices.

## Related Officers

- [Regulatory Officer ](https://www.globalkeysolutions.net/people/jill-tillman/4fd81eed-0de2-468b-a776-d4809fa91553)

Company: https://www.globalkeysolutions.net/companies/conopco-inc/7ea57e14-27dd-432e-a45a-5af402cdb9e5

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-ii/8851d151-0390-4d17-be66-fd86d12aa6b8